ARv7 enhances the MALT1/NF-κB-signaling pathway in an androgen-independent way to motivate cell proliferation, invasion, and tumor growth in human androgen-independent prostate cancer cells in vitro and in vivo. Here, NFKB1 is linked to neoplasm.